Process Validation: A 17-Year Retrospective of Solid-Dosage Forms
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 22 (1) , 25-34
- https://doi.org/10.3109/03639049609043869
Abstract
The author takes the reader through the various stages, phases, and steps in the product and process development sequence of solid-dosage form design (tablet and capsule) using process validation principles and practices as a guide. The challenge for the pharmaceutical industry as it approaches the next millennium is to streamline and/or simplify validation requirements without sacrificing product quality and process flexibility. Cost-containment pressures in the future will necessitate the use of more process automation and innovative ways of manufacturing products. In the final analysis, these objectives can best be accomplished with the cooperation of a worldwide regulatory commitment to achieving harmonization goals for both good manufacturing practices and process validation.Keywords
This publication has 6 references indexed in Scilit:
- Statistical Design and Analysis in Pharmaceutical SciencePublished by Taylor & Francis ,2018
- When is it Appropriate to Average and its Relationship to the Barr DecisionClinical Research and Regulatory Affairs, 1994
- A Response to Recent Gmp-Validation InterpretationsClinical Research and Regulatory Affairs, 1993
- The Ever-Changing Standards of Cgmp: United States V. Barr Laboratories, IncClinical Research and Regulatory Affairs, 1993
- Scaleup of Oral Extended-Release Dosage FormsPharmaceutical Research, 1993
- Scaleup of Immediate Release Oral Solid Dosage FormsPharmaceutical Research, 1993